TUBEROUS SCLEROSIS

 

TUBEROUS SCLEROSIS

 

DEFINITION:

A neurocutaneous syndrome characterized by cutaneous and neurologic manifestations (mental retardation and seizures), and tumors.

EPIDEMIOLOGY:

  • incidence: 1/30,000
  • age of onset:
    • 1st decade
  • risk factors:
    • familial - autosomal dominant with variable penetrance
      • chrom.#: 9q33-34 (Type 1)
      • ?11q23 (Type 2)
      • ?12q23.3 (Type 3)
      • 16p13 (Type 4)
    • if 2 or more siblings with Tuberous Sclerosis (TS) then one parent always has at least one skin manifestation of TS
    • sporadic rate varies from 58-77%
    • if both parents are normal the TS in a child is probably a new mutation

HISTORY:

    1880-1900 - Bourneville and Brissaud

    • first pathologic description of TS
    • first to call the disease tuberous sclerosis
    • first to relate cerebral sclerosis to the renal tumors

    1908 - Vogt

    • emphasized association of adenoma sebaceum & cerebral sclerosis
    • emphasized cardiac and renal tumors are constituents of TS
    • triad: mental retardation (MR), seizures, adenoma sebaceum

PATHOLOGY:

1. Tubers

  • basic cause is unknown but considered a disorder of early embryogenesis
  • greater the # of tubers the greater the neurologic impairment
  • found anywhere within the cerebral hemispheres:
    • typically present in the subependymal region (located in the walls of the lateral ventricles and on the surface of the basal ganglia) and may extend into the ventricles
    • in the region of the foramen of Monro where they may cause obstruction -> hydrocephalus
    • also cortical gyri, sulcus terminalis

2. Sclerosis

  • areas of:
    • decreased numbers of neurons
    • areas of increased numbers of oddly-shaped, multinucleated "monster" giant neurons
    • proliferation (overgrowth) of fibrillary astrocytes which occasionally differentiate into malignant astrocytomas
    • demyelination
    • calcium deposition in gliotic areas
    • blood vessels with hyaline degeneration of their walls

CLINICAL FEATURES:

  • clinical presentation is extremely variable depending on the age of the patient, which organs are involved, and the severity of involvement
  • clinical variability even within the same family

1. Cutaneous Manifestations

1. Adenoma Sebaceum (80%)

  • rarely present at birth
  • usually presents between 4-6 years of age:
    • are present in 12% at 1 year
    • are present in 33% at 2 years
    • are present in 40% at 3 years
  • are angiofibromas:
    • usually pink or red papules appearing in patches or in a butterfly-shaped distribution on or about the nose, cheeks, and chin
    • with time may enlarge, coalesce, and assume a fleshy appearance

2. Ash-leaf Spots (90%)

  • hypopigmented oval or leaf-shaped spots
  • vary in size from mm -> cm
  • vary in number from several to 75 or more
  • found on the trunk and limbs in a linear orientation
  • apparent at birth and seen prior to 2 years in 50% of patients
  • visualized using a Wood's light (melanin absorbs wavelengths at 360 nm)
  • represent depigmented macules inwhich the melanocytes are normal but the melanosomes are reduced in number and contain less melanin

3. Shagreen Patches (35%)

  • isolated "leathery" raised and thickened plaques
  • have an orange-peel consistency
  • may be grayish-green or light brown in colour
  • found over the lumbosacral or gluteal region
  • develop in late infancy or early childhood but may also be present at birth
  • may be preceded by patches of grey or white hair (these hairy patches may be the first manifestation of TS)

4. Others

  • cafe-au-lait spots (7-16%)
  • fibromas:
    • flattened and can appear on the trunk, gingivae, periungual region, and along the hairline or eyebrows
  • angiomas

2. Neurologic Manifestations

1. Seizures (90%)

  • most common symptom of TS
  • initally present as infantile spasms:
    • 25-50% of patients with infantile spasms later develop signs of TS
    • can appear as early as 1 week of age
  • later develop other types of generalized seizures:
    • tonic, clonic, myoclonic, akinetic, Lennox-Gastaut Syndrome
  • epileptogenic focus may occur independently of tubers

2. Mental Retardation (60-70%)

  • highly variable but when present is irreversible
  • may be initally normal but then deteriorate intellectually during the latter part of the 1st decade (secondary to seizure or increased intracranial pressure)
  • earlier the onset of seizures the greater the likelihood of mental retardation (if seizures begin <1 year of age a 92% chance of MR)
  • all who have mental retardation (MR) have had seizures
  • 33% of TS have normal intelligence

3. Others

  • hydrocephalus:
    • if tubers obstruct the foramina of Monro or the
    • Sylvian aqueduct
  • developmental delay
  • may develop autistic features

3. Tumors

1. Retinal (50-80%)

1. Mulberry Tumor

  • a nodular astrocytoma of the retina on or about the optic nerve head
  • refractile, yellowish, multinodular cystic lesions

2. Hamartomas

  • round or oval grey-yellow glial flat patches found centrally or peripherally
  • complications do not include papilledema or impaired vision

2. Renal (50-80%)

1. Angiomyolipomas

  • multiple yellow-white nodules or cystic tumors embedded within the parenchyma
  • usually benign but may cause hematuria, pain, and renal failure

3. Heart (50%)

1. Cardiac Rhabdomyomas

  • solitary or multiple; infiltrative and/or diffuse
  • solitary lesions usually found at the apex of the left ventricle
  • may cause congestive heart failure or arrhythmias but tend to slowly resolve spontaneously
  • may cause death before skin manifestations evident

4. Cutaneous (20%)

1. Koenen's Tumors

  • subungual or periungual fibromas
  • usually first appear in adolescence
  • toes > fingers

5. Intracranial (15%)

1. Astrocytomas

  • fibrillary astrocytomas may differentiate into giant cell astrocytomas
  • occur around the walls of the lateral ventricle or the anterior portion of the 3rd ventricle
  • may present as:
    • elevated intracranial pressure (papilledema, headache, nausea, vomiting)
    • diminished vision
    • lateralizing signs (hemiparesis)

6. Oral

  • oral fibromas or papillomas
  • usually found on the anterior aspect of the gingiva

4. Other Manifestations

1. Respiratory

  • lesions in lungs are either cystic or fibrous
  • angiomyolipomas may produce these generalized multicystic or fibrous pulmonary changes
  • may present with SOBE, and/or spontaneous pneumothorax
  • females more affected than males

2. Musculoskeletal

  • cystic changes and periosteal thickening of bones in hands and feet

INVESTIGATIONS:

1. Imaging Studies

1. CT

  • 1. Intracranial Calcifications (60%)
    • most reliable finding in TS is calcified subependymal tubers
    • also occur in the region of the foramina of Monro and periventricular regions
    • multiple scattered calcium deposits may vary in size up to several cm
    • occur as early as 5 months and become more prominent with time (typically around 3-4 years of age)
  • 2. Others
    • only 5% of patients with the clinical features of TS have normal CT's
    • may also identify cerebral atrophy, subependymal tumors, ventriculomegaly, and areas of diffuse demyelination
  • 2. MRI

    • preferable for the visualization of cortical tubers, areas of heteropias, and hamartomas
    • tubers which project into the lateral and 3rd ventricles may appear as "candle drippings"
    • important to identify heteropias as these may act as seizure foci

    3. Skeletal X-Rays

    • cystic rarefaction of phalanges and metacarpals (67%) appear around puberty
    • sclerotic areas of long bones
    • areas of variable skull bone density with thickened calvaria

    4. Chest X-Rays

    • fine reticular infiltrates and/or multicystic changes

    2. EEG

    1. Infantile Spasms

    • hypsarrhythmias, can persist up to 8 years of age

    2. Generalized Seizures

    • generalized slow wave-and-spike activity or independent multifocal spike discharges

    3. Cerebral Spinal Fluid

    • elevated protein with elevated intracranial pressure (ICP)

    MANAGEMENT:

    1. Supportive

    • a multidisciplinary approach involving:
      • Paediatrics, Neurology, Ophthalmology, Nephrology, Cardiology, Dermatology, Neurosurgery, Orthopedics, PT, OT, Respirology
      • ensure regular follow-up for tumor surveillence
      • supplemental education

    2. Cutaneous Manifestations

    • surgical resection if lesions are continually irritated or subjected to trauma

    3. Neurologic Manifestations

    1. Infantile Spasms

    • hormonal therapy: ACTH, prednisone
    • anticonvulsants: clonazepam, VPA, nitrazepam, clobazam
    • ? pertussis immunization -> triggers infantile spasm
      • recommend not giving pertussis immunization to infants with TS

    2. Generalized Seizures

    • anticonvulsant therapy and may be difficult to control

    3. Developmental delay

    • physiotherapy, early intervention

    4. Tumors

    1. Surgical Resection

    • of intracranial tumors if complications:
      • elevated ICP -> hydrocephalus
      • malignant transformation
    • of other tumors if complications:
      • cardiac -> congestive heart failure or arrhythmias
      • renal -> renal failure

    5. Others

    1. Genetic Couselling

    • 25% of parents without personal or family history of TS may be shown by careful history, physical (Wood's light, fundoscopic exam), & investigations (CT, renal ultrasound) to be affected
    • incompletely affected parents (those with isolated findings such as adenoma sebaceum, retinal hamartomas, viseral tumors) can have children with complete TS

    INTERNET LINKS:

    National Tuberous Sclerosis Association

     

    Pediatric Database - TUBEROUS SCLEROSIS

    Pediatric Organization - Pedbase [at] Gmail.com